Synthesis and characterization of PVP-coated large core iron oxide nanoparticles as an MRI contrast agent

The purpose of this study was to synthesize biocompatible polyvinylpyrrolidone (PVP)-coated iron oxide (PVP-IO) nanoparticles and to evaluate their efficacy as a magnetic resonance imaging (MRI) contrast agent. The PVP-IO nanoparticles were synthesized by a thermal decomposition method and character...

Full description

Saved in:
Bibliographic Details
Published inNanotechnology Vol. 19; no. 16; p. 165101
Main Authors Lee, Ha-Young, Lee, Sang-Hoon, Xu, Chenjie, Xie, Jin, Lee, Jin-Hyung, Wu, Bing, Leen Koh, Ai, Wang, Xiaoying, Sinclair, Robert, Wang, Shan X, Nishimura, Dwight G, Biswal, Sandip, Sun, Shouheng, Cho, Sun Hang, Chen, Xiaoyuan
Format Journal Article
LanguageEnglish
Published England IOP Publishing 23.04.2008
Online AccessGet full text

Cover

Loading…
More Information
Summary:The purpose of this study was to synthesize biocompatible polyvinylpyrrolidone (PVP)-coated iron oxide (PVP-IO) nanoparticles and to evaluate their efficacy as a magnetic resonance imaging (MRI) contrast agent. The PVP-IO nanoparticles were synthesized by a thermal decomposition method and characterized by x-ray diffraction (XRD), transmission electron microscopy (TEM), dynamic light scattering (DLS), and a superconducting quantum interface device (SQUID). The core size of the particles is about 8-10 nm and the overall size is around 20-30 nm. The measured r(2) (reciprocal of T(2) relaxation time) and r2∗ (reciprocal of T2∗ relaxation time) are 141.2 and 338.1 (s mM)(-1), respectively. The particles are highly soluble and stable in various buffers and in serum. The macrophage uptake of PVP-IO is comparable to that of Feridex as measured by a Prussian blue iron stain and phantom study. The signal intensity of a rabbit liver was effectively reduced after intravenous administration of PVP-IO. Therefore PVP-IO nanoparticles are potentially useful for T(2)-weighted MR imaging.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0957-4484
1361-6528
DOI:10.1088/0957-4484/19/16/165101